Fei Li

8111618, Feb 7, 2012

Jan 27, 2006

11/342372

Fei Li - Piscataway NJ, US
Marina K. Thottan - Westfield NJ, US

Alcatel Lucent - Paris

H04J 1/16
H04J 3/14
H04L 1/00
H04L 12/26
H04L 12/28
H04L 12/16

370229, 370230, 3702301, 370231, 370232, 370233, 370234

The need to monitor real time network services has prompted service providers to use new measurement technologies, such as service-specific probes. A service-specific probe is an active probe that closely mimics the service traffic so that it receives the same treatment from the network as the actual service traffic. Service-specific probes are end-to-end and their deployment depends on solutions that address questions such as minimizing probe traffic, while still obtaining maximum coverage of all the links in the network. A polynomial-time probe-path computation algorithm is provided as well as a 2-approximate solution for merging probe paths when the number of probes exceeds a required bound k. The algorithms are evaluated using ISP topologies generated via Rocketfuel. For most topologies, it is possible to cover more than about 98% of the edges using just about 5% of the nodes as terminals.

20050025064, Feb 3, 2005

Mar 31, 2004

10/813865

Shu-Ping Chang - Shrub Oak NY, US
Fei Li - New York NY, US
James Lipscomb - Yorktown Heights NY, US

International Business Machines Corporation - Armonk NY

H04L012/26
H04J003/14

370252000, 370235000, 370395210

Techniques for adaptive QoS include selecting, based on one or more QoS criteria corresponding to a client, one or more given data items suitable for sending to the client in response to a query from the client. The one or more given data items are selected from a set of data items. One or more statistics are associated with the one or more data items. The one or more statistics are useable to modify which data items are included in the set of data items. The statistics may be used by removing unpopular data items, as determined by the statistics, from the set of data items in the communication system. Additionally, data items exceeding the one or more QoS criteria can be transcoded to create new data items meeting the one or more QoS criteria, and the new data items can be added to the set of data items in the communication system. Thus, the set of data items can be changed depending on current demand by users for particular data items.

20220356264, Nov 10, 2022

May 6, 2022

17/738805

- New York NY, US
Hai HU - New York NY, US
Fei LI - New York NY, US

C07K 16/30
A61P 35/00
C07K 16/28

Provided are methods for cancer therapy. The method comprises inhibiting the expression and/or activity of ATF7IP and/or SETDB1 in cancer cells. Also provided is a method for identifying individuals for cancer therapy that includes using ATF7IP and/or SETDB1 inhibition.

20170152283, Jun 1, 2017

Dec 6, 2016

15/371032

- Bethesda MD, US
- University Park PA, US
Cen Xie - Rockville MD, US
Andrew D. Patterson - State College PA, US
Fei Li - Rockville MD, US
James B. Mitchell - Damascus MD, US
Shantu Amin - Union City NJ, US
Dhimant Desai - Mechanicsburg PA, US

The United States of America, as represented by the Secretary, Dept. of Health and Human Services - Bethesda MD
The Penn State Research Foundation - University Park PA

C07J 41/00
C07J 31/00

Disclosed are inhibitors of the farnesoid X receptor, for example of formula (I), wherein R, R, R, X, Y, Z, m, and n are as defined herein, which are useful in treating or preventing obesity, type 2 diabetes/insulin resistance and non-alcoholic fatty liver disease in a mammal in need thereof. Also disclosed is a composition comprising a pharmaceutically suitable carrier and at least one compound of the invention, a method of method of inhibiting a farnesoid X receptor in a mammal, and a method of treating or preventing obesity in a mammal.

20160159851, Jun 9, 2016

Aug 1, 2014

14/909263

- Bethesda MD, US
- University Park PA, US
Cen Xie - Rockville MD, US
Andrew D. Patterson - State College PA, US
Fei Li - Rockville MD, US
James B. Mitchell - Damascus MD, US
Shantu Amin - Union City NJ, US
Dhimant Desai - Mechanicsburg PA, US

The United Sates of America, as represented by the Secretary, Department of Health and Human Service - Bethesda MD
The Penn State Research Foundation - University Park PA

C07J 41/00

Disclosed are inhibitors of the farnesoid X receptor, for example of formula (I), wherein R, R, R, X, Y, Z, m, and n are as defined herein, which are useful in treating or preventing obesity, type 2 diabetes/insulin resistance and non alcoholic fatty liver disease in a mammal in need thereof. Also disclosed is a composition comprising a pharmaceutically suitable carrier and at least Cone compound of the invention, a method of method of inhibiting a farnesoid X receptor in a mammal, and a method of treating or preventing obesity in a mammal.